Concepedia

V. Nienaber

VN

Statistics

Publications

28

Citations

1.7K

H-Index

21

Active since

1992

Affiliations

Abbott Fund(Current)

Zenobia Therapeutics (United States)

Lawrence Berkeley National Laboratory

Palo Alto Research Center

Abbott (United Kingdom)

V. Nienaber is an author at Abbott Fund specializing in structural biology, drug discovery, and life sciences.

Publications per year

1992–2017

28

Publications

28

Discovering novel ligands for macromolecules using X-ray crystallographic screening

V. Nienaber, Paul L. Richardson, Vered Klighofer et al. · Nature Biotechnology · 2000 · 320 citations

, , +14

A Novel Mode of Gleevec Binding Is Revealed by the Structure of Spleen Tyrosine Kinase

S. Atwell, J.M. Adams, John Badger et al. · Journal of Biological Chemistry · 2004 · 192 citations · Full text

, , +13

Novel Inhibitors of Erm Methyltransferases from NMR and Parallel Synthesis

Philip J. Hajduk, Jürgen Dinges, Jeffrey M. Schkeryantz et al. · Journal of Medicinal Chemistry · 1999 · 119 citations · Full text

, , +16

Crystal Structure of ErmC‘, an rRNA Methyltransferase Which Mediates Antibiotic Resistance in Bacteria

Dirksen E. Bussiere, Steven W. Muchmore, Christopher G. Dealwis et al. · Biochemistry · 1998 · 110 citations

, , +15

Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury

Michał Pyzik, Timo Räth, Timothy Kuo et al. · Proceedings of the National Academy of Sciences · 2017 · 104 citations · Full text

, , +17

1–5 of 28